Clinical Trials

Name of TrialDescription
​The Gilead – DIVERSITY Study​A study to evaluate the efficacy and safety of the orally administered drug Filgotinib for the treatment of active Crohn’s disease.​ 
​Creatine Supplementation Study​​A study to evaluate dietary creatine supplementation for the reduction of mucosal inflammation through improved epithelial barrier function of active Ulcerative colitis.
AbbVie M20-371 AIM-CD

A Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD).

Please contact Gianna Morales for more information: